Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer

Plain-language summary

This study examined the relationship between endometrial cancer and the PTEN tumour suppressor gene using a questionnaire, DNA testing from blood samples and tumour genetic markers. Patients aged 18 and older who had a hysterectomy and were able to provide consent and complete the questionnaire were included. It was a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

University Health Network, Toronto

Intervention

questionnaire, Blood sample-DNA testing / Tumour-genetic markers

Start date

4/1/2000

Estimated completion

10/1/2011

Countries

Canada

Related genes

Locations

• Toronto, Canada

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Age 18 and older
* patients who had a hysterectomy
* patient able to provide consent and complete questionnaire